Serum prohepcidin concentrations in rheumatoid arthritis.
OBJECTIVE
Hepcidin, a recently identified peptide, acts as a central regulator of iron metabolism. It is regarded as a factor regulating the uptake of dietary iron and its mobilisation from macrophages and hepatic stores. It is considered as a mediator of anaemia of inflammation. The aim of this study was to assess whether serum prohepcidin concentration is able to distinguish iron deficiency from anaemia of inflammation in patients with rheumatoid arthritis (RA).


METHODS
Blood samples were obtained from 20 healthy blood donors, 30 RA patients who presented with anaemia and 30 patients who had pure iron deficiency anaemia (IDA). The samples were analysed for full blood count, iron, ferritin, transferrin, soluble transferrin receptor and prohepcidin.


RESULTS
The mean prohepcidin level in the control subjects was 256 microg/L. The prohepcidin level was significantly lower in IDA patients (100 microg/L; p < 0.0001) but not significantly different from that of control in RA patients (250 microg/L; p > 0.05). Higher serum soluble transferrin receptor (sTfR) levels were observed in IDA (p < 0.0001) but not in RA compared with that of control (p > 0.05). RA patients were divided into iron depleted and iron repleted subgroups based on the ferritin level. Prohepcidin in the iron depleted group was significantly lower than the iron repleted group and the control (p < 0.0001) and higher levels were observed in the iron repleted group (p < 0.01). sTfR levels in the iron depleted group were significantly higher than the control and the iron repleted patients (p < 0.001). In the iron repleted group, sTfR level was not statistically different from that of control (p > 0.05).


CONCLUSIONS
Serum prohepcidin is clearly reduced in uncomplicated iron deficiency anaemia. The reduced prohepcidin levels in the iron depleted RA patients suggests that there may be conflicting signals regulating hepcidin production in RA patients. In RA patients who have reduced hepcidin in the iron depleted group (ferritin <60 microg/L) where sTfR levels are increased suggests that these patients are iron deficient. Further studies with a larger cohort of patients are required to substantiate this point.
Jayaranee
S
S
Department of Pathology, Faculty of Medicine, University of Malaya, Lembah Pantai, Kuala Lumpur, Malaysia. jayaranee@um.edu.my
Sthaneshwar
Pavai
P
Sokkalingam
Sargunan
S
D000328:Adult; D000740:Anemia / Q000097:blood / Q000175:diagnosis / Q000209:etiology; D018798:Anemia, Iron-Deficiency / Q000097:blood* / Q000175:diagnosis; D023181:Antimicrobial Cationic Peptides / Q000097:blood*; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000150:complications / Q000175:diagnosis; D015415:Biomarkers / Q000097:blood*; D003937:Diagnosis, Differential; D005260:Female; D064451:Hepcidins; D006801:Humans; D007249:Inflammation / Q000097:blood* / Q000150:complications / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D011498:Protein Precursors / Q000097:blood*; D011990:Receptors, Transferrin / Q000097:blood
D023181:Antimicrobial Cationic Peptides; D015415:Biomarkers; D064451:Hepcidins; D011498:Protein Precursors; D011990:Receptors, Transferrin